Related references
Note: Only part of the references are listed.LaPO4 Nanoparticles Doped with Actinium-225 that Partially Sequester Daughter Radionuclides
Jonathan Woodward et al.
BIOCONJUGATE CHEMISTRY (2011)
Alpha- versus Beta-Particle Radiopeptide Therapy in a Human Prostate Cancer Model (213Bi-DOTA-PESIN and 213Bi-AMBA versus 177Lu-DOTA-PESIN)
Damian Wild et al.
CANCER RESEARCH (2011)
Radiometallated peptides for molecular imaging and targeted therapy
Joao D. G. Correia et al.
DALTON TRANSACTIONS (2011)
Somatostatin Receptor-Targeted Radionuclide Therapy in Patients with Gastroenteropancreatic Neuroendocrine Tumors
Dik J. Kwekkeboom et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
Targeted Radiotherapy with Radio labeled Somatostatin Analogs
Guillaume Nicolas et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2011)
177Lu-immunotherapy of experimental peritoneal carcinomatosis shows comparable effectiveness to 213Bi-immunotherapy, but causes toxicity not observed with 213Bi
Christof Seidl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2011)
Renal uptake of bismuth-213 and its contribution to kidney radiation dose following administration of actinium-225-labeled antibody
J. Schwartz et al.
PHYSICS IN MEDICINE AND BIOLOGY (2011)
Radioimmunotherapy of Solid Tumors: Searching for the Right Target
Hong Song et al.
CURRENT DRUG DELIVERY (2011)
Conventional and pretargeted radioimmunotherapy using bismuth-213 to target and treat non-Hodgkin lymphomas expressing CD20: a preclinical model toward optimal consolidation therapy to eradicate minimal residual disease
Steven I. Park et al.
BLOOD (2010)
Improved Efficacy of α-Particle-Targeted Radiation Therapy
Diane E. Milenic et al.
CANCER (2010)
Immunoliposomal Delivery of 213Bi for α-Emitter Targeting of Metastatic Breast Cancer
Mohanambe Lingappa et al.
CANCER RESEARCH (2010)
Selective Killing of Tumor Neovasculature Paradoxically Improves Chemotherapy Delivery to Tumors
Freddy E. Escorcia et al.
CANCER RESEARCH (2010)
Sequential Cytarabine and α-Particle Immunotherapy with Bismuth-213-Lintuzumab (HuM195) for Acute Myeloid Leukemia
Todd L. Rosenblat et al.
CLINICAL CANCER RESEARCH (2010)
Assessment of long-term radiotoxicity after treatment with the low-dose-rate alpha-particle-emitting radioimmunoconjugate Th-227-rituximab
Jostein Dahle et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
D. Cordier et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
Repeated Intraperitoneal alpha-Radioimmunotherapy of Ovarian Cancer in Mice
Jorgen Elgqvist et al.
JOURNAL OF ONCOLOGY (2010)
Biodistributions, Myelosuppression, and Toxicities in Mice Treated with an Anti-CD45 Antibody Labeled with the α-Emitting Radionuclides Bismuth-213 or Astatine-211
Hirohisa Nakamae et al.
CANCER RESEARCH (2009)
Radioimmunotherapy of Breast Cancer Metastases with α-Particle Emitter 225Ac: Comparing Efficacy with 213Bi and 90Y
Hong Song et al.
CANCER RESEARCH (2009)
Inhibition of Micrometastatic Prostate Cancer Cell Spread in Animal Models BY 213Bilabeled Multiple Targeted α Radioimmunoconjugates
Yong Li et al.
CLINICAL CANCER RESEARCH (2009)
Intraperitoneal α-Particle Radioimmunotherapy of Ovarian Cancer Patients: Pharmacokinetics and Dosimetry of 211At-MX35 F(ab′)2-A Phase I Study
Hakan Andersson et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Intravesical α-Radioimmunotherapy with 213Bi-Anti-EGFR-mAb Defeats Human Bladder Carcinoma in Xenografted Nude Mice
Birgit Pfost et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Treatment of Peritoneal Carcinomatosis by Targeted Delivery of the Radio-Labeled Tumor Homing Peptide 213Bi-DTPA-[F3]2 into the Nucleus of Tumor Cells
Enken Drecoll et al.
PLOS ONE (2009)
Evidence of Extranuclear Cell Sensitivity to Alpha-Particle Radiation Using a Microdosimetric Model. I. Presentation and Validation of a Microdosimetric Model
N. Chouin et al.
RADIATION RESEARCH (2009)
Radioimmunotherapy of human bladder cancer in a nude mouse model comparing Bi-213-anti-EGFR-MAb and Th-226-anti-EGFR-MAb
Birgit Pfost et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Preclinical evaluation of the α-particle generator nuclide 225Ac for somatostatin receptor radiotherapy of neuroendocrine tumors
Matthias Miederer et al.
CLINICAL CANCER RESEARCH (2008)
Clinical experience with alpha-particle-emitting At-211: Treatment of recurrent brain tumor patients with At-211-labeled chimeric antitenascin monoclonal antibody 81C6
Michael R. Zalutsky et al.
JOURNAL OF NUCLEAR MEDICINE (2008)
Development and evaluation of peptidic ligands targeting tumour-associated urokinase plasminogen activator receptor (uPAR) for use in alpha-emitter therapy for disseminated ovarian cancer
Sebastian Knoer et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2008)
213Bi-induced death of HSC45-M2 gastric cancer cells is characterized by G2 arrest and up-regulation of genes known to prevent apoptosis but induce necrosis and mitotic catastrophe
Christof Seidl et al.
MOLECULAR CANCER THERAPEUTICS (2007)
213Bi-radioimmunotherapy defeats early-stage disseminated gastric cancer in nude mice
Roswitha Beck et al.
CANCER SCIENCE (2007)
Interim analysis of oxicity and response in phase 1 trial of systemic targeted alpha therapy for metastatic melanoma
Chand Raja et al.
CANCER BIOLOGY & THERAPY (2007)
Mitigation of radiation nephropathy after internal α-particle irradiation of kidneys
JS Jaggi et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2006)
213Bi-[DOTA0,Tyr3]octreotide peptide receptor radionuclide therapy of pancreatic tumors in a preclinical animal model
JP Norenberg et al.
CLINICAL CANCER RESEARCH (2006)
Fractionated locoregional low-dose radioimmunotherapy improves survival in a mouse model of diffuse-type gastric cancer using a 213Bi-conjugated monoclonal antibody
S Bloechl et al.
CLINICAL CANCER RESEARCH (2005)
Production of Ac-225 from Th-229 for targeted α therapy
C Apostolidis et al.
ANALYTICAL CHEMISTRY (2005)
Renal tubulointerstitial changes after internal irradiation with α-particle-emitting actinium daughters
JS Jaggi et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)
Cell death triggered by alpha-emitting 213Bi-immunoconjugates in HSC45-M2 gastric cancer cells is different from apoptotic cell death
C Seidl et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2005)
Cyclotron production of Ac-225 for targeted alpha therapy
C Apostolidis et al.
APPLIED RADIATION AND ISOTOPES (2005)
Nucleolin expressed at the cell surface is a marker of endothelial cells in angiogenic blood vessels
S Christian et al.
JOURNAL OF CELL BIOLOGY (2003)
Tumor therapy with targeted atomic nanogenerators
MR McDevitt et al.
SCIENCE (2001)